Ufonia Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
44
- Latest Deal Type
-
2ndary - Private
- Investors
-
18
Ufonia General Information
Description
Developer of an AI-driven voice technology designed to replace routine patient healthcare interactions with automated phone calls. The company's technology offers autonomous, automated, telephone-based clinical follow-up to capture patient-reported outcome measures, enabling healthcare organizations to monitor health and wellness through a conversational voice bot.
Contact Information
Website
www.ufonia.comCorporate Office
- 2nd Floor Percy House
- 33 Gresse Street
- London W1T 1QU
- England, United Kingdom
Corporate Office
- 2nd Floor Percy House
- 33 Gresse Street
- London W1T 1QU
- England, United Kingdom
Ufonia Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 15. Secondary Transaction - Private | 01-Jun-2026 | Completed | Generating Revenue | |||
| 14. Accelerator/Incubator | 01-Jan-2026 | Completed | Generating Revenue | |||
| 13. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 12. Later Stage VC | 28-Mar-2025 | Completed | Generating Revenue | |||
| 11. Accelerator/Incubator | 01-Oct-2024 | Completed | Generating Revenue | |||
| 10. Seed Round | 07-Sep-2022 | Completed | Generating Revenue | |||
| 9. Grant | 14-Apr-2022 | Completed | Generating Revenue | |||
| 8. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 7. Angel (individual) | 03-Oct-2020 | $260K | $260K | Completed | Generating Revenue | |
| 6. Grant | 08-Sep-2020 | $664K | Completed | Generating Revenue |
Ufonia Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary | ||||||||
| Seed Preferred Shares | ||||||||
| Ordinary | 1,600 | $0.001183 | $30.52 | $30.52 | 1x | $30.52 | 1.13% | |
| Ordinary | 6,400 | $0.001183 | $29.57 | $29.57 | 1x | $29.57 | 4.53% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Ufonia Signals
Ufonia Investors (18)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Propel Healthtech | Accelerator/Incubator | |||
| Grow London | Accelerator/Incubator | |||
| Ctrl Group | Corporation | Minority | ||
| Octopus Ventures | Venture Capital | Minority | ||
| Qubit Health Capital | Venture Capital | Minority |
Ufonia FAQs
-
When was Ufonia founded?
Ufonia was founded in 2017.
-
Where is Ufonia headquartered?
Ufonia is headquartered in London, United Kingdom.
-
What is the size of Ufonia?
Ufonia has 44 total employees.
-
What industry is Ufonia in?
Ufonia’s primary industry is Business/Productivity Software.
-
Is Ufonia a private or public company?
Ufonia is a Private company.
-
What is Ufonia’s current revenue?
The current revenue for Ufonia is .
-
How much funding has Ufonia raised over time?
Ufonia has raised $4.44M.
-
Who are Ufonia’s investors?
Propel Healthtech, Grow London, Ctrl Group, Octopus Ventures, and Qubit Health Capital are 5 of 18 investors who have invested in Ufonia.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process